Combined Multiomics and In Silico Approach Uncovers PRKAR1A as a Putative Therapeutic Target in Multi-Organ Dysfunction Syndrome
暂无分享,去创建一个
M. Serajuddin | M. Chopra | A. Rahmani | Prithvi Singh | M. Syed | Faris A Alrumaihi | Mohd Mohsin | Armiya Sultan | Ravins Dohare | S. Almatroodi | P. Jha | Prakash Jha | Mohd Mabood Khan | Madhu Chopra
[1] L. Qin,et al. Selected by bioinformatics and molecular docking analysis, Dhea and 2–14,15-Eg are effective against cholangiocarcinoma , 2022, PloS one.
[2] Cheng Zhu,et al. An integrative network-based approach for drug target indication expansion , 2021, PloS one.
[3] A. Nierhaus,et al. Sepsis—Pathophysiology and Therapeutic Concepts , 2021, Frontiers in Medicine.
[4] W. Wang,et al. Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis , 2021, Frontiers in Cellular and Infection Microbiology.
[5] Barbara Zdrazil,et al. Moving targets in drug discovery , 2020, Scientific Reports.
[6] Xiaomin Shen,et al. Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis , 2020, Journal of Intensive Care.
[7] G. Sygitowicz,et al. Molecular mechanisms of organ damage in sepsis: an overview , 2020, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[8] Manar G Gebriel,et al. Evaluation of Procalcitonin, C-Reactive Protein, and Interleukin-6 as Early Markers for Diagnosis of Neonatal Sepsis , 2020, International journal of microbiology.
[9] S. Meng,et al. Diagnostic value of serum soluble triggering expressed receptor on myeloid cells 1 (sTREM-1) in suspected sepsis: a meta-analysis , 2020, BMC Immunology.
[10] Jisoo Lee,et al. Metabolomics and the Microbiome as Biomarkers in Sepsis. , 2020, Critical care clinics.
[11] Jussi Paananen,et al. An omics perspective on drug target discovery platforms , 2019, Briefings Bioinform..
[12] J. John,et al. Differential discounting in the economic evaluation of healthcare programs , 2019, Cost Effectiveness and Resource Allocation.
[13] Muming Yu,et al. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis , 2019, Cell Death & Disease.
[14] C. Pierrakos,et al. The use of soluble urokinase plasminogen activator receptor (suPAR) as a marker of sepsis in the emergency department setting. A current review , 2019, Acta clinica Belgica.
[15] H. Puthalakath,et al. Sepsis: Inflammation Is a Necessary Evil , 2019, Front. Cell Dev. Biol..
[16] J. Timsit,et al. Septic shock among patients with systemic lupus erythematosus: Short and long-term outcome. Analysis of a French nationwide database. , 2019, The Journal of infection.
[17] Wenping Zhang,et al. Circulating microRNAs as biomarkers for Sepsis secondary to pneumonia diagnosed via Sepsis 3.0 , 2019, BMC Pulmonary Medicine.
[18] M. Pinsky,et al. Cardiovascular determinants of resuscitation from sepsis and septic shock , 2019, Critical Care.
[19] M. Hayakawa,et al. Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems , 2019, Journal of critical care.
[20] Albert-László Barabási,et al. Network-based prediction of drug combinations , 2019, Nature Communications.
[21] Pilhan Kim,et al. Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury , 2019, European Respiratory Journal.
[22] J. Koyner,et al. Sepsis associated acute kidney injury , 2019, British Medical Journal.
[23] Damian Szklarczyk,et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..
[24] R. Bellomo,et al. Sepsis‐induced acute kidney injury: A disease of the microcirculation , 2018, Microcirculation.
[25] Geetanjali Dang,et al. Severe sepsis and cardiac arrhythmias. , 2018, Annals of translational medicine.
[26] L. Moldawer,et al. Chronic Critical Illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome , 2018, Front. Immunol..
[27] Daniel Brodie,et al. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment , 2018, JAMA.
[28] Anna-Maria Burgdorff,et al. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms , 2018, The Journal of international medical research.
[29] C. Sergi,et al. Cardiovascular dysfunction in sepsis at the dawn of emerging mediators. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[30] Song-Tao Shou,et al. Sepsis-Induced Cardiomyopathy: Mechanisms and Treatments , 2017, Front. Immunol..
[31] Henry E. Wang,et al. Risk of Acute Coronary Heart Disease After Sepsis Hospitalization in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] Xuhua Xia,et al. Bioinformatics and Drug Discovery , 2017, Current topics in medicinal chemistry.
[33] Matthew J. Maiden,et al. Acute kidney injury in sepsis , 2017, Intensive Care Medicine.
[34] N. Kissoon,et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future , 2017, Intensive Care Medicine.
[35] Alan E. Jones,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[36] C. Evans,et al. Impact of thrombosis on pulmonary endothelial injury and repair following sepsis. , 2017, American journal of physiology. Lung cellular and molecular physiology.
[37] F. Tacke,et al. Liver — guardian, modifier and target of sepsis , 2017, Nature Reviews Gastroenterology &Hepatology.
[38] M. Passariello,et al. Hemodynamic coherence in sepsis. , 2016, Best practice & research. Clinical anaesthesiology.
[39] C. Ronco,et al. Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation , 2016, Kidney and Blood Pressure Research.
[40] M. Koçak,et al. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial , 2016, Critical Care.
[41] J. Takala,et al. Understanding circulatory failure in sepsis , 2016, Intensive Care Medicine.
[42] R. Hotchkiss,et al. Sepsis and septic shock , 2016, Nature Reviews Disease Primers.
[43] Sreenivas Enaganti,et al. Molecular docking and pharmacophore studies of heterocyclic compounds as Heat shock protein 90 (Hsp90) Inhibitors , 2016, Bioinformation.
[44] D. Warren,et al. Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[45] Andrew D. Rouillard,et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update , 2016, Nucleic Acids Res..
[46] Sang-Bum Hong,et al. Sepsis and Acute Respiratory Distress Syndrome: Recent Update , 2016, Tuberculosis and respiratory diseases.
[47] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[48] R. Veach,et al. New paradigms in sepsis: from prevention to protection of failing microcirculation , 2015, Journal of thrombosis and haemostasis : JTH.
[49] W. McGee,et al. The Economic and Humanistic Burden of Severe Sepsis , 2015, PharmacoEconomics.
[50] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[51] G. Van den Berghe,et al. Cholestatic liver (dys)function during sepsis and other critical illnesses , 2015, Intensive Care Medicine.
[52] Shulin Li,et al. The Role of the Liver in Sepsis , 2014, International reviews of immunology.
[53] Venu M. Velagapudi,et al. Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis. , 2014, Journal of critical care.
[54] Q. Zou,et al. Presepsin as a novel sepsis biomarker , 2014 .
[55] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[56] V. Pettilä,et al. Acute kidney injury in patients with severe sepsis in Finnish Intensive Care Units , 2013, Acta anaesthesiologica Scandinavica.
[57] Edward Y. Chen,et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.
[58] N. Nesseler,et al. The liver in sepsis , 2012 .
[59] A. Khwaja. KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.
[60] Arthur S Slutsky,et al. Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .
[61] P. Bruneval,et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration , 2010, Intensive Care Medicine.
[62] Ravi Iyengar,et al. Network analyses in systems pharmacology , 2009, Bioinform..
[63] S. Bagshaw,et al. Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy , 2009, Intensive Care Medicine.
[64] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[65] Daniel Talmor,et al. Occult hypoperfusion and mortality in patients with suspected infection , 2007, Intensive Care Medicine.
[66] Jenine K. Harris,et al. Network Analysis in Public Health: History, Methods, and Applications , 2022 .
[67] A. Mebazaa,et al. Septic shock: a heart story since the 1960s , 2006, Intensive Care Medicine.
[68] C. Sprung,et al. Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.
[69] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[70] G. Su,et al. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[71] V. Pettilä,et al. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis , 2002, Intensive Care Medicine.